Zacks Investment Research
13 Nov 2025, 23:16 UTC · 44w ago
Verdict
Headline leans bearish. We score CODX −0.20 across three claims.
Score confirms the headline.
Leans bearish
From its wording — no explicit rating
−0.20slightly bearish
What the story claims
3 claims · scored −1 bearish … +1 bullish
Co-Diagnostics reported quarterly revenues of $0.15 million, missing the Zacks Consensus Estimate by 51.67%.
So whatA significant revenue miss of over 50% and a sharp decline from year-ago levels ($0.64M) indicates a severe contraction in business growth.
More negative than 97% of claims this week
Co-Diagnostics shares have declined approximately 47.2% since the beginning of the year.
Continue reading
5 related stories
More negative than 76% of ticker scores this week
Scored by the NIS engine · methodology.
More negative than 76% of claims this week
Co-Diagnostics reported a quarterly adjusted loss of $0.16 per share, beating the consensus estimate of a $0.19 loss.
More positive than 49% of claims this week
Which stocks this story touches
More negative than 76% of ticker scores this week
The company reported a revenue miss of 51.67% and shares have lost 47.2% year-to-date, despite a small earnings beat.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
GlobeNewsWire
1h ago
−91.5%
Price agrees with the score
$0.9457 vs $11.16 close before publication (Nov 13) · not market-adjusted
CODX chart →
